Agnieszka Jankowska

Dr. Agnieszka Jankowska

Department of Paediatrics, Gastroenterology, Allergology and Paediatric Nutrition, Medical University of Gdańsk
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
AJAgnieszka Jankowska
Agnieszka Jankowska
MBMichał Brzeziński
Michał Brzeziński
ARAnna Romanowicz-Sołtyszewska
Anna Romanowicz-Sołtyszewska
ASAgnieszka Szlagatys-Sidorkiewicz
Agnieszka Szlagatys-Sidorkiewicz
The prevalence of childhood obesity is increasing worldwide. Some obese children can go on to develop metabolic syndrome (MetS), but exactly who among them remains to be determined. The aim of this study was to indicate predisposing factors for metabolic syndrome, especially those that can be modified. The study comprised 591 obese children aged 10–12 years. They were all Caucasian residents of Gdańsk, Poland, with similar demographic backgrounds. Clinical examination, anthropometry, biometric impedance analysis, blood tests (including oral glucose tolerance tests (OGTT) and insulinemia), and dietary and physical activity evaluation were conducted. The results of our study show that the risk factors for MetS or any of its components include male sex, parental (especially paternal) obesity, low body mass at birth, as well as omitting breakfast or dinner. There are few risk factors for metabolic syndrome both in obese adults and children. Some of these predictors can be modified, especially those in relation to lifestyle. Identifying and then influencing these factors may help to reduce the development of metabolic syndrome and consequently improve health and quality of life.

15 April 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
MBMichał Brzeziński
Michał Brzeziński
AJAgnieszka Jankowska
Agnieszka Jankowska
MSMagdalena Słomińska-Frączek
Magdalena Słomińska-Frączek
Paulina MetelskaPaulina Metelska
Paulina Metelska
Piotr WiśniewskiPiotr Wiśniewski
Piotr Wiśniewski
ASAgnieszka Szlagatys-Sidorkiewicz
Agnieszka Szlagatys-Sidorkiewicz
Background: Vitamin D was studied in regards to its possible impact on body mass reduction and metabolic changes in adults and children with obesity yet there were no studies assessing the impact of vitamin D supplementation during a weight management program in children and adolescence. The aim of our study was to assess the influence of 26 weeks of vitamin D supplementation in overweight and obese children undergoing an integrated 12–months’ long weight loss program on body mass reduction, body composition and bone mineral density. Methods: A double–blind randomized placebo–controlled trial. Vitamin D deficient patients (<30 ng/ml level of vitamin D) aged 6–14, participating in multidisciplinary weight management program were randomly allocated to receiving vitamin D (1200 IU) or placebo for the first 26 weeks of the intervention. Results: Out of the 152 qualified patients, 109 (72%) completed a full cycle of four visits scheduled in the program. There were no difference in the level of BMI (body mass index) change – both raw BMI and BMI centiles. Although the reduction of BMI centiles was greater in the vitamin D vs. placebo group (−4.28 ± 8.43 vs. −2.53 ± 6.10) the difference was not statistically significant (p = 0.319). Similarly the reduction in fat mass—assessed both using bioimpedance and DEXa was achieved, yet the differences between the groups were not statistically significant. Conclusions: Our study ads substantial results to support the thesis on no effect of vitamin D supplementation on body weight reduction in children and adolescents with vitamin D insufficiency undergoing a weight management program.

JSJoanna Szczyrska
Joanna Szczyrska
AJAgnieszka Jankowska
Agnieszka Jankowska
MBMichał Brzeziński
Michał Brzeziński
MJMarek Jankowski
Marek Jankowski
Paulina MetelskaPaulina Metelska
Paulina Metelska
ASAgnieszka Szlagatys-Sidorkiewicz
Agnieszka Szlagatys-Sidorkiewicz
Excess body weight is a serious public health problem, which affects both adults and children. Unfortunately, the prevalence of excess body weight in children in Poland is not subject to any regular screening. The aim of this study was to analyze the prevalence of overweight and obesity in 6–7-year-old children in the municipality of Gdańsk in the years 2008–2016. The anthropometric parameters of 12,330 children (49.55% girls and 50.45% boys) with a mean age of 6.53 ± 0.38 years were analyzed. The prevalence of overweight was 7.49% (7.91% girls and 7.07% boys) and obesity 4.24% (4.47% girls and 3.99% of boys). There was no difference in the prevalence of neither overweight nor obesity between boys and girls (p = 0.076). However, the prevalence of overweight and obesity combined is higher in girls (12.38% vs. 11.06%, p = 0.023). There were no statistically significant differences in the prevalence of overweight and obesity neither in the group of girls nor in the group of boys in children aged 6–7 years in yearly cohorts examined between 2008 and 2016. The prevalence of excess body weight in this population is at a stable level.

18 January 2022 in Genes
Verified
Journal Article
Open access
PDF file
MBMateusz Biela
Mateusz Biela
MRMalgorzata Rydzanicz
Malgorzata Rydzanicz
AJAgnieszka Jankowska
Agnieszka Jankowska
ASAgnieszka Szlagatys-Sidorkiewicz
Agnieszka Szlagatys-Sidorkiewicz
ARAnna Rozensztrauch
Anna Rozensztrauch
RŚRobert Śmigiel
Robert Śmigiel
Until 2021, the ZNF699 gene was not associated with any human genetic disease. There were only two studies exploring the associations between variants in ZNF699 and alcohol dependence. In 2021 Bertoli-Avella et al. reported 13 patients with a ZNF699 gene mutation. All patients presented global developmental delay and with systemic manifestations. A new phenotype was proposed and called DEGCAGS syndrome (OMIM 619488) (developmental delay with gastrointestinal, cardiovascular, genitourinary, and skeletal abnormalities). The DEGCAGS syndrome is inherited in the autosomal recessive mode. Here, we report a new case (14th up to date) of a patient with ZNF699 gene mutation, whose symptoms and dysmorphic features were similar to those presented by Bertoli-Avella et al. In addition, we have analyzed the frequency of occurrence of particular symptoms in the patients described so far.

29 May 2020 in European Journal of Translational and Clinical Medicine
Verified
Journal Article
Open access
KKKatarzyna Kaźmierska
Katarzyna Kaźmierska
ALAleksandra Lemanowicz-Kustra
Aleksandra Lemanowicz-Kustra
AJAgnieszka Jankowska
Agnieszka Jankowska
ASAgnieszka Szlagatys-Sidorkiewicz
Agnieszka Szlagatys-Sidorkiewicz
ESEwa Sapiejka
Ewa Sapiejka

20 May 2020 in Research Square
Verified
Preprint
Open access
PDF file
AJAgnieszka Jankowska
Agnieszka Jankowska
MBMichał Brzeziński
Michał Brzeziński
ARAnna Anna Romanowicz-Sołtyszewska
Anna Anna Romanowicz-Sołtyszewska
ASAgnieszka Szlagatys - Sidorkiewicz
Agnieszka Szlagatys - Sidorkiewicz
Background: Prevalence of childhood obesity increases worldwide. Some of the obese children develop metabolic syndrome (MetS) , who of them - remains to be determined. The aim of this study was indicate predisposing factors for metabolic syndrome,, especially those which can be modified.Methods: The study comprised 591 obese children aged 10-12 years. Clinical examination, anthropometry, biometric impedance analysis, blood works (incl. OGGT and insulinemia) as well as dietary evaluation and physical activity were estimated. Results: The risk factors of MetS or feature of this are: male, parent’s especially father’s obesity, low body mass at birth as well as omitting breakfast or dinner.Conclusions: There are few risk factors of metabolic syndrome in obese subjects, also in obese children. Some of these predictors can me modified, especially those referring to lifestyle. Indicating and then influencing these factors can be one way to diminish metabolic syndrome development, such improving health and quality of life. Besides certain socioeconomic effects could be gain too.